The Maker of OxyContin has a New Way to Profit from the Opioid Crisis
Purdue Pharma Looks at Pivoting to Addiction Medications Hundreds of thousands dead. Countless other lives derailed by an addiction that refused to break. This is the story of the opioid epidemic in America—and too many of us are personally familiar with the pain it brings when it strikes. For those affected, things may never be […]
by Sam Dekin
Read More: The Maker of OxyContin has a New Way to Profit from the Opioid Crisis